Cell Signaling Glycogen Synthase 2 (Gys2) Antibody

Name: Cell Signaling Glycogen Synthase 2 (Gys2) Antibody
SKU: CSIG-98348S
Price: 320.17 USD

List Price $320.17 Your Price $320.17

Cell Signaling Glycogen Synthase 2 (Gys2) Antibody - CSIG (Additional S&H or Hazmat Fees May Apply)

NETA PART: CSIG-98348S

MFG.PART: 98348S

UNSPSC: 12352203

Manufacturer: Cell Signaling

Description

Size	100 µl
Reactivity	H M R
Sensitivity	Endogenous
Molecular Weight (kDa)	84
Source/Isotype	Rabbit
Application/Dilution	{Western Blotting: 1:1000}
Storage	Supplied in 10 mm sodium HEPES (pH 7.5), 150 mm NaCl, 100 µg/mL BSA, and 50% glycerol. Store at –20°C. Do not aliquot the antibody.
Specificity/Sensitivity	Glycogen Synthase 2 (GYS2) Antibody recognizes endogenous levels of total GYS2 protein. This antibody does not cross-react with GYS1 protein.
Species Reactivity	Human, Mouse, Rat
Source/Purification	Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu679 of human GYS2 protein. Antibodies are purified by peptide affinity chromatography.
Background	Glycogen is a polysaccharide of glucose and serves as an energy storage in mammalian muscle and liver (1). Glycogen synthase catalyzes the rate-limiting step of glycogen biosynthesis and has two major isoforms in mammals: muscle isoform (glycogen synthase 1, GYS1) and liver isoform (glycogen synthase 2, GYS2), respectively (1). Glycogen synthase kinase-3α (GSK-3α) and glycogen synthase kinase-3β (GSK-3β) phosphorylate glycogen synthase at multiple sites in its C-terminus (Ser641, Ser645, Ser649, and Ser653), inhibiting its activity (2,3). Hypoxia alters glycogen metabolism including temporal changes of GYS1 expression and phosphorylation in cancer cells, suggesting the role of metabolic reprogramming of glycogen metabolism in cancer growth (1).

Specifications